
Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review
Description
Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review
- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Heska Corp (Heska) is an animal health care company, engaged in the development, manufacturing and commercialization of veterinary diagnostic and specialty products for canine and feline companion animal health. The company’s major products include digital imaging diagnostic instruments, point of care laboratory instruments and consumables, software and services, allergy testing and immunotherapy, local and cloud-based data services, digital cytology services and others. Heska other products also include single use offerings such as in-clinic diagnostic tests and heartworm preventive products. It also provides vaccines and other pharmaceuticals for cattle including porcine, avian, equine, feline and canine. It has a direct presence in the US, Canada, Mexico, Germany, Switzerland, Australia, France, Spain, and others. Heska is headquartered in Loveland, Colorado, the US.
Heska Corp Key Recent Developments
Apr 21,2023: Heska Announces Annual Meeting of Stockholders on May 3, 2023
Feb 28,2023: Heska Corporation Reports Fourth Quarter and Full Year 2022 Results
Feb 08,2023: Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023
Nov 08,2022: Heska Corporation Reports Third Quarter 2022 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
60 Pages
- Section 1 - About the Company
- Heska Corp - Key Facts
- Heska Corp - Key Employees
- Heska Corp - Key Employee Biographies
- Heska Corp - Major Products and Services
- Heska Corp - History
- Heska Corp - Company Statement
- Heska Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Heska Corp - Business Description
- Business Segment: International
- Overview
- Performance
- Target Markets
- Key Stats
- Business Segment: North America
- Overview
- Performance
- Target Markets
- Key Stats
- Geographical Segment: Canada
- Performance
- Geographical Segment: France
- Performance
- Geographical Segment: Germany
- Performance
- Geographical Segment: Italy
- Performance
- Geographical Segment: Other International
- Performance
- Geographical Segment: Spain
- Performance
- Geographical Segment: Switzerland
- Performance
- Geographical Segment: United States
- Performance
- R&D Overview
- Heska Corp - Corporate Strategy
- Heska Corp - SWOT Analysis
- SWOT Analysis - Overview
- Heska Corp - Strengths
- Heska Corp - Weaknesses
- Heska Corp - Opportunities
- Heska Corp - Threats
- Heska Corp - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Heska Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Heska Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Heska Corp, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Apr 21, 2023: Heska Announces Annual Meeting of Stockholders on May 3, 2023
- Feb 28, 2023: Heska Corporation Reports Fourth Quarter and Full Year 2022 Results
- Feb 08, 2023: Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023
- Nov 08, 2022: Heska Corporation Reports Third Quarter 2022 Results
- May 09, 2022: Heska Corp Reports First Quarter 2022 Results
- Apr 18, 2022: Heska First Quarter 2022 Financial Results and Earnings Call Scheduled for May 9, 2022
- Apr 14, 2022: Heska Announces its Annual Meeting of Stockholders on May 4, 2022
- Feb 28, 2022: Heska Corporation Reports Fourth Quarter and Full Year 2021 Results
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Heska Corp, Key Facts
- Heska Corp, Key Employees
- Heska Corp, Key Employee Biographies
- Heska Corp, Major Products and Services
- Heska Corp, History
- Heska Corp, Other Locations
- Heska Corp, Subsidiaries
- Heska Corp, Key Competitors
- Heska Corp, Ratios based on current share price
- Heska Corp, Annual Ratios
- Heska Corp, Annual Ratios (Cont...1)
- Heska Corp, Annual Ratios (Cont...2)
- Heska Corp, Interim Ratios
- Heska Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Heska Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Heska Corp, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Heska Corp, Performance Chart (2018 - 2022)
- Heska Corp, Ratio Charts
- Heska Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Heska Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.